// App-Quantinova.ai

155 : Limitations of Estimated FRAX 10-Year Fracture Risk at the Time of Incident Fracture and Upon Refracture: Results from the OPTIMUS Initiative

Researchers

Presenter

  • Pierre-Marc April

Principal Investigators

  • Francois Cabana

  • Sophie Roux

  • Marie-Claude Beaulieu

  • Michele Beaulieu

  • Gilles Boire

Medical Centers

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

  • Centre hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada

Locations

  • Canada

Companies

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoporosis

Biomarkers

  • Bone Mineral Density

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved